When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SNPHF - FDA accepts Santen application for severe allergic eye disease
Santen Pharmaceutical Co. Ltd.
The FDA accepts for review Santen Pharmaceutical Co., Ltd.'s (SNPHF) marketing application seeking approval of cyclosporine topical ophthalmic emulsion, 0.1% for the treatment of severe vernal keratoconjunctivitis, an allergic eye disease common in boys, in young patients ages 4-18.The agency's action date is June 26, 2021.